Suppr超能文献

应对新冠疫情:基于冠状病毒进化和分子特征的研究策略

Managing the COVID-19 Pandemic: Research Strategies Based on the Evolutionary and Molecular Characteristics of Coronaviruses.

作者信息

Majid Sabhiya, Farooq Rabia, Khan Mosin S, Rashid Samia, Bhat Showkat A, Wani Hilal A, Qureshi Waseem

机构信息

Department of Biochemistry, Government Medical College Srinagar and Associated Hospitals , Srinagar, J&K 190010 India.

Department of Basic Medical Sciences, University of Bisha, Bisha, 67714 Saudi Arabia.

出版信息

SN Compr Clin Med. 2020;2(10):1767-1776. doi: 10.1007/s42399-020-00457-z. Epub 2020 Aug 25.

Abstract

Coronavirus disease 2019 (COVID-19), an ongoing global health emergency, is a highly transmittable and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Emerging in Wuhan, China, in December 2019, it spread widely across the world causing panic-worst ever economic depression is visibly predictable. Coronaviruses (CoVs) have emerged as a major public health concern having caused three zoonotic outbreaks; severe acute respiratory syndrome-CoV (SARS-CoV) in 2002-2003, Middle East respiratory syndrome-CoV (MERS-CoV) in 2012, and currently this devastating COVID-19. Research strategies focused on understanding the evolutionary origin, transmission, and molecular basis of SARS-CoV-2 and its pathogenesis need to be urgently formulated to manage the current and possible future coronaviral outbreaks. Current response to the COVID-19 outbreak has been largely limited to monitoring/containment. Although frantic global efforts for developing safe and effective prophylactic and therapeutic agents are on, no licensed antiviral treatment or vaccine exists till date. In this review, research strategies for coping with COVID-19 based on evolutionary and molecular aspects of coronaviruses have been proposed.

摘要

2019冠状病毒病(COVID-19)是一场持续的全球卫生突发事件,是由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的一种高度传染性和致病性的病毒感染。2019年12月在中国武汉出现后,它在全球广泛传播,导致了恐慌——有史以来最严重的经济衰退显然是可以预见的。冠状病毒(CoV)已成为一个主要的公共卫生问题,曾引发三次人畜共患病疫情;2002 - 2003年的严重急性呼吸综合征冠状病毒(SARS-CoV)、2012年的中东呼吸综合征冠状病毒(MERS-CoV),以及目前这场毁灭性的COVID-19。迫切需要制定侧重于了解SARS-CoV-2的进化起源、传播、分子基础及其发病机制的研究策略,以应对当前及未来可能出现的冠状病毒疫情。目前对COVID-19疫情的应对主要局限于监测/控制。尽管全球正在疯狂努力研发安全有效的预防和治疗药物,但迄今为止尚无获得许可的抗病毒治疗方法或疫苗。在这篇综述中,基于冠状病毒的进化和分子方面,提出了应对COVID-19的研究策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8538/7445016/e2df14019420/42399_2020_457_Fig1_HTML.jpg

相似文献

1
Managing the COVID-19 Pandemic: Research Strategies Based on the Evolutionary and Molecular Characteristics of Coronaviruses.
SN Compr Clin Med. 2020;2(10):1767-1776. doi: 10.1007/s42399-020-00457-z. Epub 2020 Aug 25.
2
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
3
COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.
Molecules. 2020 Dec 23;26(1):39. doi: 10.3390/molecules26010039.
4
COVID-19: Diagnostics, Therapeutic Advances, and Vaccine Development.
Curr Clin Microbiol Rep. 2021;8(3):152-166. doi: 10.1007/s40588-021-00157-9. Epub 2021 Feb 15.
5
Current Strategies of Antiviral Drug Discovery for COVID-19.
Front Mol Biosci. 2021 May 13;8:671263. doi: 10.3389/fmolb.2021.671263. eCollection 2021.
6
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4.
7
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
Front Immunol. 2020 May 12;11:1022. doi: 10.3389/fimmu.2020.01022. eCollection 2020.
8
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses.
J Adv Res. 2020 Mar 16;24:91-98. doi: 10.1016/j.jare.2020.03.005. eCollection 2020 Jul.
10
Human and novel coronavirus infections in children: a review.
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.

引用本文的文献

本文引用的文献

1
Wuchang Fangcang Shelter Hospital: Practices, Experiences, and Lessons Learned in Controlling COVID-19.
SN Compr Clin Med. 2020;2(8):1029-1034. doi: 10.1007/s42399-020-00382-1. Epub 2020 Jul 4.
2
The Association of Cardiovascular Diseases and Diabetes Mellitus with COVID-19 (SARS-CoV-2) and Their Possible Mechanisms.
SN Compr Clin Med. 2020;2(8):1077-1082. doi: 10.1007/s42399-020-00376-z. Epub 2020 Jun 25.
4
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.
Mol Cell. 2020 May 21;78(4):779-784.e5. doi: 10.1016/j.molcel.2020.04.022. Epub 2020 May 1.
5
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
Science. 2020 Jun 19;368(6497):1331-1335. doi: 10.1126/science.abb4489. Epub 2020 Apr 22.
6
Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2.
Emerg Infect Dis. 2020 Jul;26(7):1542-1547. doi: 10.3201/eid2607.200092. Epub 2020 Jun 21.
7
An Epidemiological Study on COVID-19: A Rapidly Spreading Disease.
Cureus. 2020 Mar 18;12(3):e7313. doi: 10.7759/cureus.7313.
8
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.
J Thromb Haemost. 2020 Jun;18(6):1324-1329. doi: 10.1111/jth.14859.
9
COVID-19 Outbreak: an Update on Therapeutic Options.
SN Compr Clin Med. 2020;2(4):379-380. doi: 10.1007/s42399-020-00264-6. Epub 2020 Apr 1.
10
The proximal origin of SARS-CoV-2.
Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验